Ex parte PARK et al. - Page 2




          Appeal No. 96-1852                                                          
          Application No. 08/016,931                                                  


               This is an appeal from the final rejection of claim 1-13               
          and 15-22, all the claims remaining in the present                          
          application.  Claims 1, 12 and 13 are illustrative:                         
               1.  A method for inhibiting the formation of deposits on               
          a contact lens comprising:                                                  
               introducing into a mammalian eye wearing a contact lens                
          an ophthalmically acceptable composition comprising an                      
          ophthalmically acceptable antioxidant component in an amount                
          effective to inhibit the formation of at least one of                       
          proteinaceous deposits and lipid deposits on said contact                   
          lens.                                                                       
               12. A method for conditioning a contact lens comprising:               
               soaking a contact lens which is proteinaceous deposit-                 
          free  in an ophthalmically acceptable composition comprising                
          an ophthalmically acceptable aqueous carrier component, an                  
          ophthalmically acceptable wearability component in an amount                
          effective to enhance the wearability of said soaked contact                 
          lens in a mammalian eye, and an ophthalmically acceptable                   
          antioxidant component in an amount effective to inhibit the                 
          formation of at least one of proteinaceous deposits and lipid               
          deposits on said soaked contact lens after said soaked contact              
          lens is placed in a mammalian eye, said ophthalmically                      
          acceptable antioxidant component being selected from the group              
          consisting of Vitamin A, Vitamin E, ascorbic acid,                          
          glutathione, oxidation-type gluta-thione, ophthalmically                    
          acceptable antioxidant salts thereof, ophthalmically                        
          acceptable antioxidant derivatives thereof, precursors thereof              
          and mixtures thereof.                                                       
               13. A composition useful for inhibiting the formation of               
          deposits on a contact lens being worn in a mammalian eye                    
          comprising:                                                                 
               an ophthalmically acceptable aqueous carrier component;                


                                         -2-                                          




Page:  Previous  1  2  3  4  5  6  7  8  9  10  Next 

Last modified: November 3, 2007